BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2531148)

  • 1. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
    Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
    Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quantitative analysis of D2-dopamine receptors in baboon striatum in vivo with 3-N-[2'-18F]fluoroethylspiperone using positron emission tomography.
    Jovkar S; Wienhard K; Pawlik G; Coenen HH
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):720-6. PubMed ID: 2384543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography.
    Satyamurthy N; Bida GT; Barrio JR; Luxen A; Mazziotta JC; Huang SC; Phelps ME
    Int J Rad Appl Instrum B; 1986; 13(6):617-24. PubMed ID: 3494003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
    Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
    J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography (PET) in the study of dopamine receptors in the primate brain: evaluation of a kinetic model using 11C-N-methyl-spiperone.
    Eckernäs SA; Aquilonius SM; Hartvig P; Hägglund J; Lundqvist H; Någren K; Långström B
    Acta Neurol Scand; 1987 Mar; 75(3):168-78. PubMed ID: 3495092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P; Guan HC; Niznik HB
    Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol.
    Karbe H; Wienhard K; Hamacher K; Huber M; Herholz K; Coenen HH; Stöcklin G; Lövenich A; Heiss WD
    J Neural Transm Gen Sect; 1991; 86(3):163-73. PubMed ID: 1837996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacological profile of 3-N-(2-fluoroethyl)spiperone.
    Goffinet AM; Leysen J; Labar D
    J Cereb Blood Flow Metab; 1990 Jan; 10(1):140-2. PubMed ID: 2137131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography (PET) study: the effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP, SUN 0588) on the central dopamine D1, D2 and D3 receptors in rhesus monkey.
    Tani Y; Ishihara T; Kanai T; Ohno T; Onoe H; Watanabe Y; Andersson J; Lilija A; Westerberg G; Hartvig P
    Adv Exp Med Biol; 1993; 338():327-30. PubMed ID: 8304130
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization.
    Chugani DC; Ackermann RF; Phelps ME
    J Cereb Blood Flow Metab; 1988 Jun; 8(3):291-303. PubMed ID: 2966803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding.
    Halldin C; Farde L; Högberg T; Hall H; Ström P; Ohlberger A; Solin O
    Int J Rad Appl Instrum B; 1991; 18(8):871-81. PubMed ID: 1839303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding.
    Perlmutter JS; Moerlein SM; Hwang DR; Todd RD
    J Neurosci; 1991 May; 11(5):1381-9. PubMed ID: 1827499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone.
    Hägglund J; Aquilonius SM; Eckernäs SA; Hartvig P; Lundquist H; Gullberg P; Långström B
    Acta Neurol Scand; 1987 Feb; 75(2):87-94. PubMed ID: 2953165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age-related decrease of 11C-N-methylspiperone in vivo binding to human striatum detected by PET].
    Iyo M; Yamasaki T; Fukuda H; Inoue O; Suzuki K; Shinotoh H; Ito T; Yonezawa H; Nishio M; Koseki A
    Kaku Igaku; 1989 Feb; 26(2):213-20. PubMed ID: 2525202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET.
    Delforge J; Loc'h C; Hantraye P; Stulzaft O; Khalili-Varasteh M; Mazière M; Syrota A; Mazière B
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):914-25. PubMed ID: 1834685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
    Logan J; Wolf AP; Shiue CY; Fowler JS
    J Neurochem; 1987 Jan; 48(1):73-83. PubMed ID: 2432176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.